Category: Vaccines
Global Vaccines
-
Global Oral Vaccines Competitive Landscape Professional Research Report 2024
... traditional vaccines, which are injected, oral vaccines are designed to stimulate an immune response in the gastrointestinal system. They often contain weakened or inactivated forms of the pathogen, allowing the body to develop immunity without ... Read More
-
Global Encephalitis Vaccination Competitive Landscape Professional Research Report 2024
... caused by viral infections. There are different types of encephalitis, often associated with specific viruses, such as Japanese encephalitis, tick-borne encephalitis, or West Nile virus. Vaccines are available for some of these viral strains and ... Read More
-
Global Hepatitis B Vaccines Competitive Landscape Professional Research Report 2024
... The vaccines work by stimulating the immune system to produce antibodies that provide immunity to the virus. Hepatitis B is commonly transmitted through contact with infected blood, unprotected sexual activity, or from an infected mother ... Read More
-
Global Travelers Vaccines Competitive Landscape Professional Research Report 2024
... against specific diseases that may be prevalent or pose a risk in certain regions of the world. Common travel vaccines include those for diseases such as hepatitis A and B, typhoid, yellow fever, meningitis, and ... Read More
-
Global Brucellosis Vaccines Competitive Landscape Professional Research Report 2024
... livestock such as cattle, goats, and pigs, as well as humans. The vaccines developed for brucellosis primarily target livestock populations, as they play a significant role in transmission to humans through consumption of contaminated animal ... Read More
-
Global Dengue Vaccines Competitive Landscape Professional Research Report 2024
... Aedes albopictus. The vaccines are designed to stimulate the immune system to produce antibodies against the dengue virus, preventing or reducing the severity of the infection if a vaccinated person is exposed to the virus. ... Read More
-
Global Yellow Fever Vaccines Competitive Landscape Professional Research Report 2024
... is a serious viral illness that can lead to severe illness and even death in some cases. The yellow fever vaccine is based on a live attenuated virus strain called 17D, which was developed in ... Read More
-
Global Human Vaccines Competitive Landscape Professional Research Report 2024
... typically contain weakened or inactivated forms of pathogens, or components of pathogens, which prompt the body to produce an immune response without causing the actual disease. When a person is vaccinated, their immune system learns ... Read More
-
Global Swine Vaccines Competitive Landscape Professional Research Report 2024
... system to produce antibodies against specific pathogens, thereby preventing or reducing the severity of illnesses. Swine vaccines are crucial in the agricultural industry to maintain herd health, improve animal welfare, and prevent economic losses due ... Read More
-
Global DPT Vaccines Competitive Landscape Professional Research Report 2024
... These vaccines are typically given as a series of shots to infants and young children, followed by booster doses during adolescence and adulthood to ensure continued immunity. Diphtheria can lead to severe respiratory and heart ... Read More
-
Global mRNA Vaccines and Therapeutics Competitive Landscape Professional Research Report 2024
... RNA to instruct cells in the body to produce specific proteins or trigger immune responses. In the context of vaccines, mRNA vaccines have gained significant attention for their role in protecting against infectious diseases, such ... Read More
-
Global Cell Culture Media for Vaccine Competitive Landscape Professional Research Report 2024
... the manufacturing process of vaccines. These media are designed to support the growth of specific cell lines, such as mammalian cells, insect cells, or avian cells, which are used as hosts for viral replication or ... Read More
-
Global Poultry Vaccines Competitive Landscape Professional Research Report 2024
... in preventing and controlling the spread of various viral, bacterial, and parasitic diseases that can adversely impact poultry health and production. Poultry vaccines are administered through various methods, including injection, drinking water, or spray applications. ... Read More
-
Global Avian Influenza Vaccines Competitive Landscape Professional Research Report 2024
... used as a part of disease control measures, especially in situations where there is an outbreak of avian influenza. The vaccine works by stimulating the immune system of the bird, so that it produces a ... Read More
-
Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines), End User, Age Group - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 307.02 million in 2024, at a CAGR 7.32% to reach USD 469.83 million by 2030. Cholera vaccines are biological preparations designed to protect individuals from cholera, a ... Read More
-
Vaccine Contract Manufacturing Market by Type (Attenuated Vaccine, DNA Vaccines, Inactivated Vaccine), Function (Downstream, Upstream), Application - Global Forecast 2024-2030
... expected to reach USD 5.51 billion in 2024, at a CAGR 9.21% to reach USD 9.39 billion by 2030. Vaccine contract manufacturing refers to outsourcing vaccine production processes to third-party organizations, known as contract manufacturing ... Read More
-
Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 1.82 billion in 2024, at a CAGR 6.72% to reach USD 2.70 billion by 2030. Porcine vaccines are immunological preparations designed to prevent various swine diseases in pigs. ... Read More
-
Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Global Forecast 2024-2030
... USD 9.82 billion in 2023 and expected to reach USD 10.40 billion in 2024, at a CAGR 6.43% to reach USD 15.19 billion by 2030. Veterinary vaccines are biologically prepared substances that stimulate an animal's ... Read More
-
Vaccine Adjuvants Market by Product (Adjuvant Emulsions, Combination Adjuvants, Mineral Adjuvants), Route of Administration (Intradermal, Intramuscular, Intranasal), Disease, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 884.18 million in 2024, at a CAGR 7.88% to reach USD 1,404.20 million by 2030. Vaccine adjuvants are essential components in the formulation of vaccines, which enhance and modulate ... Read More
-
Travel Vaccines Market by Type (Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines), Disease (DPT, Hepatitis A, Hepatitis B) - Global Forecast 2024-2030
... expected to reach USD 9.09 billion in 2024, at a CAGR 10.06% to reach USD 16.18 billion by 2030. The travel vaccines market encompasses the production, distribution, and administration of immunizations recommended or required for ... Read More
-
Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Age Group, Distribution - Global Forecast 2024-2030
... to reach USD 11.56 billion in 2024, at a CAGR 7.92% to reach USD 18.30 billion by 2030. The pneumococcal vaccine is designed to protect against infections caused by the streptococcus pneumoniae bacteria. These infections ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Microcarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide a surface ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
-
COVID-19 Clinical Trials Market by Product (Therapeutics, Vaccines), Phase (Phase I, Phase II, Phase III) - Global Forecast 2024-2030
... to reach USD 6.79 billion in 2024, at a CAGR 13.93% to reach USD 14.84 billion by 2030. The COVID-19 clinical trials market comprises all research activities and trials to examine the efficacy and safety ... Read More
-
Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Global Forecast 2024-2030
... USD 55.66 billion in 2023 and expected to reach USD 59.94 billion in 2024, at a CAGR 7.79% to reach USD 94.14 billion by 2030. Vaccines are biological preparations that equip the body's immune system ... Read More
Research Assistance
